Skip to content
Home/Companies/Healthcare/tranScrip
tranScrip

tranScrip

Healthcare·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns tranScrip?

tranScrip is currently owned by Palatine Private Equity through Palatine Impact Fund II (2023 vintage), since 2021.

Hand-verified · updated 2026-04-21

Palatine Private Equity
Investor
Palatine Private Equity
Palatine Impact Fund II · 2023 · Impact

Key facts

HQUK
SectorHealthcare
Websitetranscrip-group.com

More from Palatine Impact Fund II

Other portfolio companies in the same fund.

Isle Utilities
Isle Utilities
Active
Business ServicesUK· 2024
The MOLE Clinic
The MOLE Clinic
Active
HealthcareUK· 2024
Papilo
Papilo
Active
Business ServicesUK· 2023
Cura Terrae
Cura Terrae
Active
Business ServicesUK· 2022
Inclusive Employers
Inclusive Employers
Active
Business ServicesUK· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track tranScrip

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy tranScrip?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on tranScrip.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue